Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

17. Februar 2026 08:44 ET | Quelle: Liminatus Pharma, Inc.

Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering

CERRITOS, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (NASDAQ: LIMN) (“Liminatus” or the “Company”), a pre-clinical stage immuno-oncology company developing next-generation...
17. Februar 2026 08:00 ET | Quelle: ARKO CORP.

ARKO Corp. and ARKO Petroleum Corp. Announce Closing of ARKO Petroleum Corp.’s Initial Public Offering

RICHMOND, Va., Feb. 17, 2026 (GLOBE NEWSWIRE) -- ARKO Corp. (Nasdaq: ARKO) (“ARKO”) and ARKO Petroleum Corp. (Nasdaq: APC) (“APC”), today announced the closing on February 13, 2026 of APC’s initial...
13. Februar 2026 16:33 ET | Quelle: HCM IV Acquisition Corp

HCM IV Acquisition Corp. Announces Closing of $287,500,000 Initial Public Offering

NORWALK, Ct, Feb. 13, 2026 (GLOBE NEWSWIRE) -- HCM IV Acquisition Corp. (Nasdaq: HACQU) (the “Company”), a blank check company whose business purpose is to effect a merger, amalgamation, share...
12. Februar 2026 17:00 ET | Quelle: RF Acquisition Corp III

RF Acquisition Corp III Announces Pricing of $100 Million Initial Public Offering

SINGAPORE, Feb. 12, 2026 (GLOBE NEWSWIRE) -- RF Acquisition Corp III (the “Company”) today announced the pricing of its initial public offering of 10,000,000 units at a price of $10.00 per unit. The...
12. Februar 2026 16:01 ET | Quelle: OKYO Pharma LTD

OKYO Pharma Announces Public Offering of Ordinary Shares

LONDON and NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of...
12. Februar 2026 16:01 ET | Quelle: Galecto, Inc.

Galecto Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $316.3 Million

BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a biopharmaceutical company focused on developing novel therapeutics to redefine the treatment paradigm for people living with...
12. Februar 2026 15:33 ET | Quelle: Idea Acquisition Corp.

Idea Acquisition Corp. Announces Closing of $350 Million Initial Public Offering

LOS ANGELES, Calif, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Idea Acquisition Corp. (Nasdaq: IACOU) (the “Company”) today announced the closing of its initial public offering of 35,000,000 units at a...
11. Februar 2026 21:30 ET | Quelle: Society Pass Incorporated

Society Pass Incorporated Announces Pricing of $3.0 Million Public Offering of Common Stock

NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Society Pass Incorporated (Nasdaq: SOPA) (the “Company”), Southeast Asia’s (SEA) next generation e-commerce ecosystem, today announced the pricing of its...
11. Februar 2026 20:00 ET | Quelle: Spring Valley Acquisition Corp

Spring Valley Acquisition Corp. IV Announces Closing of $230 Million Initial Public Offering

Spring Valley Acquisition Corp. IV Announces Closing of $230 Million Initial Public Offering
11. Februar 2026 19:52 ET | Quelle: ARKO CORP.

ARKO Corp. and ARKO Petroleum Corp. Announce Pricing of ARKO Petroleum Corp.’s Initial Public Offering

RICHMOND, Va., Feb. 11, 2026 (GLOBE NEWSWIRE) -- ARKO Corp. (Nasdaq: ARKO) (“ARKO”) and ARKO Petroleum Corp., a subsidiary of ARKO (“APC”), today announced the pricing of APC’s initial public...

Vorherige Seite

Nächste Seite